COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 29, 2024
07/03/2024
Disclosure of Share Capital and Voting Rights Outstanding as of February 29, 2024 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 29 février 2024
07/03/2024
Nombre total de droits de vote et d’actions composant le capital social au 29 février 2024 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) [...]
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
07/03/2024
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial Officer and Chief [...]
EssilorLuxottica and Dolce&Gabbana announce 16-year licensing renewal
07/03/2024
EssilorLuxottica and Dolce&Gabbana announce 16-year licensing renewal Charenton-le-Pont, France and Milan, Italy (March 7, 2024) - EssilorLuxottica and Dolce&Gabbana, today, announce the early renewal of their [...]
EssilorLuxottica et Dolce&Gabbana annoncent le renouvellement de leur accord de licence pour 16 ans
07/03/2024
EssilorLuxottica et Dolce&Gabbana annoncent le renouvellement de leur accord de licence pour 16 ans Charenton -le-Pont, France et Milan, Italie (7 mars 2024) - EssilorLuxottica et Dolce&Gabbana annoncent aujourd [...]
DLH to Provide Information Technology Services to the National Cancer Institute
07/03/2024
ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading Health IT provider of digital transformation and cybersecurity, science research and development, and [...]
Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital
07/03/2024
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Ipsen - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/03/2024
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Healthcare Financial Management Association calls Patient Rights Advocate’s latest price transparency compliance report ‘irresponsible’
07/03/2024
CHICAGO, March 07, 2024 (GLOBE NEWSWIRE) -- Long an advocate for consumerism and price transparency in healthcare, the Healthcare Financial Management Association (HFMA) today called the latest report from Patient [...]
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
07/03/2024
UB-312 is first immunotherapy to show reduction of pathological alpha-synuclein in cerebrospinal fluid of Parkinson’s patients LISBON, Portugal, March 07, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ: VAXX ), a U.S [...]
iTeos fait le point sur ses activités et publie ses résultats financiers pour le quatrième trimestre et l’exercice 2023
07/03/2024
- Plusieurs avancées cliniques attendues en 2024, y compris deux essais de Phase II évaluant belrestotug + dostarlimab dans le CPNPC en 1re ligne et le CETC en 1re ligne - Fin de la période d’inclusion de la cohorte de [...]
Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells
07/03/2024
Company presenting an in vivo study of PT-CD16, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells at AACR Annual Meeting 2024 FLORHAM PARK, N.J., March 07, 2024 (GLOBE [...]
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
07/03/2024
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON MARCH 4, 2024 PROVIDING AN UPDATE ON AB SCIENCE DEVELOPMENT Paris, March 7, 2024, 3pm CET AB Science SA (Euronext - FR0010557264 - AB) is providing a summary of the live [...]
AB Science propose un résumé de la conférence virtuelle qui s’est tenue le 4 mars 2024, avec pour objectif de faire le point sur le développement d'AB Science
07/03/2024
COMMUNIQUÉ DE PRESSE RÉSUMÉ DE LA CONFERENCE VIRTUELLE SUR LE DÉVELOPPEMENT D’AB SCIENCE QUI S’EST TENUE LE 4 MARS 2024 Paris, le 7mars 2024, 15h AB Science SA (Euronext - FR0010557264 - AB) propose un résumé de la [...]
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
07/03/2024
Data support ongoing development program of novel CDK2/9 inhibitor fadraciclib in patients with solid tumors and lymphoma BERKELEY HEIGHTS, N.J., March 07, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ [...]
Accumulus Synergy accueille deux cadres de stature internationale dans son équipe de direction
07/03/2024
BURLINGAME, Californie, 07 mars 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (« Accumulus ») a annoncé, ce jour, la nomination de Chanille Juneau au poste de Cheffe de produit, et du Dr Kevin Charest à celui de [...]
Accumulus Synergy Adds Two World-Class Executives to Its Leadership Team
07/03/2024
BURLINGAME, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”) today announced the appointment of Chanille Juneau, Chief Product Officer, and Dr. Kevin Charest, Chief Information Security [...]
Lakeland Regional Health Residents Shine at Annual Promise Run 2024
07/03/2024
“Dr. Lyudmila Sarder, Resident Physician, Honors Late Mother in Emotional 5k Fundraiser to Conquer Cancer at the Annual Hollis Cancer Center Promise Run” Lakeland, FL, March 07, 2024 (GLOBE NEWSWIRE) -- Residents from [...]
Nanoflex Robotics Installs First Remote-Ready Robotics System in North America for Vascular Interventions
07/03/2024
The remote-ready robotics system, designed to be used for vascular interventions, was installed in The Jacobs Institute’s testing facility located within the University at Buffalo’s Canon Stroke and Vascular Research [...]

Pages